[1]
|
Coscia, F., et al. (2020) The Structure of Human Thyroglobulin. Nature, 578, 627-630.
https://doi.org/10.1038/s41586-020-1995-4
|
[2]
|
龙佩, 张雷, 何流, 等. 检测分化型甲状腺癌患者术前Tg.TgAh及TSH水平的临床分析[J]. 中国医学装备, 2017, 10(14): 97-100.
|
[3]
|
Citterio, C.E., Targovnik, H.M. and Arvan, P. (2019) The Role of Thyroglobulin in Thyroid Hormonogenesis. Nature Reviews Endocrinology, 15, 323-338. https://doi.org/10.1038/s41574-019-0184-8
|
[4]
|
张娜. 有关甲状腺球蛋白抗体与甲状腺乳头状癌131I治疗疗效关系的系列研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2018.
|
[5]
|
Szujo, S., Bajnok, L., Bodis, B., et al. (2021) The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer. Cancers, 13, Arti-cle No. 310. https://doi.org/10.3390/cancers13020310
|
[6]
|
徐淑英, 严春霞, 沈冬明. 抗甲状腺球蛋白抗体对妇女甲状腺乳头状癌发病的影响[J]. 中国肿瘤临床与康复, 2021, 28(1): 59-62.
|
[7]
|
Zou, X., Gao, F., Wang, Z.Y., et al. (2020) A Three-microRNA Panel in Serum as Novel Biomarker for Papillary Thyroid Carcinoma Diagnosis. Chi-nese Medical Journal (England), 133, 2543-2551.
https://doi.org/10.1097/CM9.0000000000001107
|
[8]
|
Hillebrand, J.J., Siegelaar, S.E. and Heijboer, A.C. (2020) Falsely Decreased Thyroglobulin Levels in a Patient with Differentiated Thyroid Carcinoma. Clinica Chimica Acta; In-ternational Journal of Clinical Chemistry, 509, 217-219.
https://doi.org/10.1016/j.cca.2020.06.027
|
[9]
|
史育红, 唐芳, 张波. 对比分析甲状腺球蛋白抗体对电化学发光法和免疫放射法测定甲状腺球蛋白的干扰[J]. 标记免疫分析与临床, 2020, 27(11): 1998-2002.
|
[10]
|
Bílek, R., Dvořáková, M., Grimmichová, T., et al. (2020) Thyroglobulin and Thyroid Gland. Physiological Research, 69, S225-S236. https://doi.org/10.33549/physiolres.934514
|
[11]
|
Bílek, R., Čeřovská, J. and Zamrazil, V. (2015) The Relationship between Iodine Intake and Serum Thyroglobulin in the General Population. Physiological Research, 64, 345-353. https://doi.org/10.33549/physiolres.932840
|
[12]
|
费扬帆, 马徐颖, 王亚平, 等. 血清Tg、TSH对分化型甲状腺癌的诊断价值[J]. 癌症进展, 2019, 17(15): 1786-1788+1816.
|
[13]
|
单凤玲, 陆汉魁. 甲状腺球蛋白实验研究进展与临床应用[J]. 中国普通外科杂志, 2017, 26(5): 648-654.
|
[14]
|
陈艳林. Tg对甲状腺自身免疫异常的DTC患者预后监测的价值[D]: [硕士学位论文]. 郑州: 郑州大学, 2013.
|
[15]
|
Kim, H., Park, S.Y., Choe, J.H., et al. (2020) Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Can-cer. Cancers, 12, Article No. 625. https://doi.org/10.3390/cancers12030625
|
[16]
|
Machens, A. and Dralle, H. (2010) Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer. The Journal of Clinical Endo-crinology and Metabolism, 95, 2655-2663. https://doi.org/10.1210/jc.2009-2368
|
[17]
|
Patell, R., Mikhael, A., Tabet, M., et al. (2018) Assessing the Utility of Preoperative Serum Thyroglobulin in Differentiated Thyroid Cancer: A Retro-spective Cohort Study. Endocrine, 61, 506-510.
https://doi.org/10.1007/s12020-018-1643-z
|
[18]
|
Oltmann, S.C., Leverson, G., Lin, S.H., et al. (2014) Markedly Elevated Thyroglobulin Levels in the Preoperative Thyroidectomy Patient Correlates with Metastatic Burden. The Journal of Surgical Research, 187, 1-5.
https://doi.org/10.1016/j.jss.2013.12.017
|
[19]
|
Li, S., Ren, C., Gong, Y., et al. (2022) The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients with Differentiated Thyroid Cancer. Frontiers in Endocrinology (Lausanne), 13, Article ID: 872527.
https://doi.org/10.3389/fendo.2022.872527
|
[20]
|
Petric, R., Perhavec, A., Gazic, B., et al. (2012) Preoperative Se-rum Thyroglobulin Concentration Is an Independent Predictive Factor of Malignancy in Follicular Neoplasms of the Thyroid Gland. Journal of Surgical Oncology, 105, 351-356.
https://doi.org/10.1002/jso.22030
|
[21]
|
McDow, A.D., Shumway, C.M., Pitt, S.C., et al. (2019) Utility of Early Postoperative Unstimulated Thyroglobulin in Influencing Decision Making in Patients with Papillary Thyroid Carcinoma. Annals of Surgical Oncology, 26, 4002-4007.
https://doi.org/10.1245/s10434-019-07581-8
|
[22]
|
Jayasekara, J., Jonker, P., Lin, J.F., et al. (2020) Early Postoper-ative Stimulated Serum Thyroglobulin Quantifies Risk of Recurrence in Papillary Thyroid Cancer. Surgery, 167, 40-45. https://doi.org/10.1016/j.surg.2019.06.048
|
[23]
|
Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., et al. (2003) A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism, 88, 1433-1441. https://doi.org/10.1210/jc.2002-021702
|
[24]
|
Hall, F.T., Beasley, N.J., Eski, S.J., et al. (2003) Predictive Value of Serum Thyroglobulin after Surgery for Thyroidcarcinoma. Laryngoscope, 113, 77-81. https://doi.org/10.1097/00005537-200301000-00014
|
[25]
|
Orlov, S., Salari, F., Kashat, L., et al. (2015) Post-Operative Stimulated Thyroglobulin and Neck Ultrasound as Personalized Criteria for Risk Stratification and Radi-oactive Iodine Selection in Low- and Intermediate-Risk Papillary Thyroid Cancer. Endocrine, 50, 130-137. https://doi.org/10.1007/s12020-015-0575-0
|
[26]
|
Xing, Z., Qiu, Y., Li, Z., et al. (2021) Predictors of Thyroglobulin in the Lymph Nodes Recurrence of Papillary Thyroid Carcinoma Undergoing Total Thyroidectomy. BMC Surgery, 21, Article No. 53.
https://doi.org/10.1186/s12893-021-01063-z
|
[27]
|
Cho, J.S. and Kim, H.K. (1993) Thyroglobulin Level as a Predic-tive Factor of Tumoral Recurrence in Differentiated Thyroid Cancer. Journal of Nuclear Medicine, 32, 395-398.
|
[28]
|
Webb, R.C., Howard, R.S., Stojadinovic, A., et al. (2012) The Utility of Serum Thyroglobulin Measure-ment at the Time of Remnant Ablation for Predicting Disease-Free Status in Patients with Differentiated Thyroid Cancer: A Meta-Analysis Involving 3947 Patients. The Journal of Clinical Endocrinology & Metabolism, 97, 2754-2763.
https://doi.org/10.1210/jc.2012-1533
|
[29]
|
Lee, S.H., Roh, J.L., Gong, G., et al. (2019) Risk Factors for Recurrence after Treatment of N1b Papillary Thyroid Carcinoma. Annals of Surgery, 269, 966-971. https://doi.org/10.1097/SLA.0000000000002710
|
[30]
|
Kim, S.J., Park, S.Y., Lee, Y.J., et al. (2014) Risk Factors for Recurrence after Therapeutic Lateral Neck Dissection for Primary Papillary Thyroid Cancer. Annals of Surgical On-cology, 21, 1884-1890.
https://doi.org/10.1245/s10434-014-3507-y
|
[31]
|
Kendler, D.B., Vaisman, F., Corbo, R., et al. (2012) Preablation Stimulated Thyroglobulin Is a Good Predictor of Successful Ablation in Patients with Differentiated Thyroid Cancer. Clinical Nuclear Medicine, 37, 545-549.
https://doi.org/10.1097/RLU.0b013e31824852f8
|
[32]
|
Stevic, I., Dembinski, T.C., Pathak, K.A., et al. (2015) Tran-sient Early Increase in Thyroglobulin Levels Post-Radioiodine Ablation in Patients with Differentiated Thyroid Cancer. Clinical Biochemistry, 48, 658-661.
https://doi.org/10.1016/j.clinbiochem.2015.04.009
|
[33]
|
Brassard, M., Borget, I., Edet-Sanson, A., et al. (2011) Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients. The Journal of Clinical Endocrinology and Metabolism, 96, 1352-1359.
https://doi.org/10.1210/jc.2010-2708
|
[34]
|
Trimboli, P., Zilioli, V., Imperiali, M., et al. (2017) High-Sensitive Basal Serum Thyroglobulin 6 - 12 Months after Thyroid Ablation Is Strongly Associated with Early Response to Therapy and Event-Free Survival in Patients with Low-to-Intermediate Risk Differentiated Thyroid Carcinomas. European Journal of Endocrinology, 5, 497-504.
https://doi.org/10.1530/EJE-16-1011
|
[35]
|
Malandrino, P., Tumino, D. and Russo, M. (2019) Surveillance of Pa-tients with Differentiated Thyroid Cancer and Indeterminate Response: A Longitudinal Study on Basal Thyroglobulin Trend. Journal of Endocrinological Investigation, 42, 1223-1230. https://doi.org/10.1007/s40618-019-01044-3
|
[36]
|
Rosario, P.W., Mourão, G.F. and Calsolari, M.R. (2019) Defini-tion of the Response to Initial Therapy with Radioiodine in Patients with Differentiated Thyroid Carcinoma: Basal or Stimulated Thyroglobulin? Hormone and Metabolic Research, 51, 634-638. https://doi.org/10.1055/a-0991-0231
|
[37]
|
Hu, H.Y., Liang, J., Zhang, T., et al. (2018) Suppressed Thyroglobulin Performs Better than Stimulated Thyroglobulin in Defining an Excellent Response in Patients with Differentiated Thyroid Cancer. Nuclear Medicine Communications, 39, 247-251. https://doi.org/10.1097/MNM.0000000000000796
|
[38]
|
Xu, S., Huang, H., Zhang, X., et al. (2021) Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma. Thy-roid, 31, 1391-1399. https://doi.org/10.1089/thy.2021.0209
|